Y-MABS THERAPEUTICS INC (YMAB)

US9842411095 - Common Stock

11.6  -0.25 (-2.11%)

After market: 11.6 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
84.49M84.82M65.27M34.90M20.75M
Cost Of Goods
11.39M11.37M7.47M2.30MN/A
Gross Profit
73.12M73.45M57.80M32.59MN/A
Operating Expenses
98.19M94.64M152.61M148.03M140.69M
Research and Development
54.08M50.87M91.57M93.25M93.70M
Selling, General, and Administrative Expenses
44.03M43.72M60.94M54.57M44.79M
Operating Income
-25.08M-21.19M-94.81M-115.43M-119.94M
Interest Income/Expense
N/A882.00K40.00K1.90M-580.00K
Other Income/Expense
4.13M3.92M-800.00K-3.75M1.17M
Non Recurring Items
N/A-4.48MN/AN/AN/A
Income Before Taxes
-20.94M-20.87M-95.57M-55.28M-119.34M
Income Tax
725.00K561.00KN/AN/AN/A
Net Income
-21.67M-21.43M-95.57M-55.28M-119.34M
EBITDA
-24.36M-20.45M-93.97M-114.65M-119.54M
 
Per Share Data
EPS Diluted Total Ops
-0.49-0.49-2.19-1.28-2.97
Non GAAP EPS
-0.49-0.49-2.18-2.72-2.97
 
Statistics
Gross Profit Margin
86.54%86.60%88.56%93.38%N/A
Profit Margin
-25.64%-25.26%-146.42%-158.40%-575.13%
Operating Profit Margin
-29.68%-24.98%-145.26%-330.74%-578.02%

All data in USD

Charts